New Test Outperforms CA-125 in Ovarian Cancer Detection
Results of the studies
The results from both ANG-001 and ANG-003 studies reveal that the best results can be achieved when combining selected genetic information with certain information relating to the patient’s condition in an algorithm. The algorithm will then be further broken down and optimized to provide the most accurate results based on the patient’s medical needs and requirements. Such results will be validated in a separate set of patients, among studies designed to meet both EU and FDA regulations. However, further details will not be disclosed until the process is thoroughly researched and complete.
